CVS Health Corporation $CVS Shares Acquired by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 26.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,258,026 shares of the pharmacy operator’s stock after acquiring an additional 472,240 shares during the quarter. Epoch Investment Partners Inc.’s holdings in CVS Health were worth $155,759,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Cantor Fitzgerald Investment Advisors L.P. grew its stake in shares of CVS Health by 1.6% during the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after purchasing an additional 6,615 shares during the period. Brandywine Global Investment Management LLC boosted its holdings in CVS Health by 20.1% during the first quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock worth $231,808,000 after buying an additional 572,533 shares in the last quarter. Holderness Investments Co. acquired a new stake in CVS Health during the first quarter valued at $300,000. Red Mountain Financial LLC purchased a new position in CVS Health in the second quarter valued at $293,000. Finally, Vanguard Group Inc. raised its position in shares of CVS Health by 0.8% in the first quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator’s stock worth $8,017,223,000 after acquiring an additional 969,027 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on CVS. Argus lifted their price target on CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research report on Monday. Zacks Research lowered CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Piper Sandler lifted their price target on shares of CVS Health from $81.00 to $99.00 in a research note on Friday, October 31st. Finally, Mizuho upped their price objective on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $90.95.

CVS Health Stock Up 2.3%

NYSE CVS opened at $76.75 on Friday. The business has a fifty day moving average price of $78.75 and a 200 day moving average price of $71.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The company has a market cap of $97.42 billion, a P/E ratio of 201.97, a P/E/G ratio of 0.73 and a beta of 0.48. CVS Health Corporation has a one year low of $43.56 and a one year high of $85.15.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. CVS Health’s dividend payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.